Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow the growth of cancer cells.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to help prevent the cancer from returning. The medication is designed to block the enzyme aromatase, which is responsible for converting androgens into estrogen. This reduction in estrogen can inhibit the growth of hormone-sensitive tumors.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users might experience nausea, dizziness, or swelling in the hands and feet. These effects can vary in intensity and duration among individuals.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. Regular monitoring of bone density may be recommended due to the potential impact on bone health. It is important to follow the advice of a healthcare provider regarding the use of this medication.

Femara may interact with other medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of estrogen-containing products should be avoided while taking Femara.